Loading...
Market
Will the average price reduction of new drugs remain at or exceed 63% by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official reports from China's National Healthcare Security Administration and pharmaceutical pricing data
Story
China Cuts Drug Prices by 63%, Adding 91 New Drugs to Insurance List, Benefiting 830 Million People
Nov 28, 2024, 07:30 AM
China's National Healthcare Security Administration announced a significant update to its national medical insurance drug list, which now includes 91 new drugs. These drugs will see an average price reduction of 63%, leading to an estimated decrease in patient costs of over 50 billion yuan (approximately $6.95 billion) in 2025. The administration reported that, as of October 2024, medication price negotiations have benefited 830 million people and reduced the cumulative financial burden on patients by CNY 880 billion (around $121.5 billion) over the past seven years. This initiative is part of China's broader efforts to expand drug coverage and improve healthcare affordability for its citizens.
View original story
Similar markets
Yes • 50%
No • 50%
Eliquis • 25%
Jardiance • 25%
Xarelto • 25%
Other • 25%
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Yes • 50%
No • 50%
10 drugs • 25%
11-15 drugs • 25%
16-20 drugs • 25%
More than 20 drugs • 25%
Less than 15% • 25%
15% to 20% • 25%
20% to 25% • 25%
More than 25% • 25%
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
Yes • 50%
No • 50%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%